Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $22,890 | 788 | 98.6% |
| Education | $321.45 | 9 | 1.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $5,410 | 155 | $0 (2024) |
| GlaxoSmithKline, LLC. | $3,674 | 144 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $2,618 | 91 | $0 (2024) |
| CSL Behring | $1,544 | 72 | $0 (2024) |
| Novo Nordisk Inc | $1,317 | 13 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $982.67 | 42 | $0 (2024) |
| GENZYME CORPORATION | $656.20 | 20 | $0 (2024) |
| PFIZER INC. | $557.55 | 27 | $0 (2024) |
| Genentech USA, Inc. | $547.95 | 12 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $546.07 | 30 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,074 | 122 | AstraZeneca Pharmaceuticals LP ($668.12) |
| 2023 | $3,471 | 137 | AstraZeneca Pharmaceuticals LP ($735.61) |
| 2022 | $3,613 | 152 | AstraZeneca Pharmaceuticals LP ($1,198) |
| 2021 | $4,182 | 142 | AstraZeneca Pharmaceuticals LP ($1,206) |
| 2020 | $1,775 | 63 | AstraZeneca Pharmaceuticals LP ($566.48) |
| 2019 | $2,664 | 64 | GlaxoSmithKline, LLC. ($454.14) |
| 2018 | $2,381 | 54 | GlaxoSmithKline, LLC. ($523.40) |
| 2017 | $2,051 | 63 | GlaxoSmithKline, LLC. ($465.81) |
All Payment Transactions
797 individual payment records from CMS Open Payments — Page 1 of 32
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $3.54 | General |
| Category: IMMUNOLOGY | ||||||
| 12/18/2024 | PFIZER INC. | PANZYGA (Biological), CUTAQUIG | Food and Beverage | In-kind items and services | $21.43 | General |
| Category: IMMUNOLOGY;INFLAMMATION | ||||||
| 12/13/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $20.93 | General |
| Category: RESPIRATORY | ||||||
| 12/13/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $0.72 | General |
| Category: RESPIRATORY | ||||||
| 12/12/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $27.99 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/29/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $6.43 | General |
| Category: RESPIRATORY | ||||||
| 11/27/2024 | CSL Behring | Hizentra (Biological) | Food and Beverage | In-kind items and services | $20.19 | General |
| Category: Immunology | ||||||
| 11/21/2024 | PFIZER INC. | ZAVZPRET (Drug) | Food and Beverage | In-kind items and services | $120.23 | General |
| Category: PAIN | ||||||
| 11/21/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.91 | General |
| Category: Respiratory | ||||||
| 11/19/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $13.88 | General |
| Category: Respiratory | ||||||
| 11/18/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $21.81 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/15/2024 | PFIZER INC. | PANZYGA (Biological), CUTAQUIG | Food and Beverage | In-kind items and services | $20.86 | General |
| Category: IMMUNOLOGY;INFLAMMATION | ||||||
| 11/14/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $17.79 | General |
| Category: Respiratory | ||||||
| 11/13/2024 | Lilly USA, LLC | — | Food and Beverage | Cash or cash equivalent | $99.89 | General |
| 11/13/2024 | X4 Pharmaceuticals, Inc. | XOLREMDI (Drug) | Food and Beverage | In-kind items and services | $15.32 | General |
| Category: Immunology | ||||||
| 11/11/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.36 | General |
| Category: Immunology | ||||||
| 11/06/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $19.35 | General |
| Category: IMMUNOLOGY | ||||||
| 11/05/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $21.12 | General |
| Category: Immunology | ||||||
| 11/01/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.35 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/29/2024 | CSL Behring | Haegarda (Biological) | Food and Beverage | In-kind items and services | $21.21 | General |
| Category: Immunology | ||||||
| 10/29/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $8.48 | General |
| Category: RESPIRATORY | ||||||
| 10/23/2024 | GENZYME CORPORATION | — | Food and Beverage | In-kind items and services | $14.76 | General |
| 10/22/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $22.68 | General |
| Category: Respiratory | ||||||
| 10/21/2024 | CSL Behring | Hizentra (Biological) | Food and Beverage | In-kind items and services | $19.54 | General |
| Category: Immunology | ||||||
| 10/19/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.25 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 997 | 11,661 | $381,689 | $104,882 |
| 2022 | 14 | 964 | 8,890 | $246,357 | $89,590 |
| 2021 | 16 | 1,206 | 10,617 | $282,572 | $109,179 |
| 2020 | 17 | 1,226 | 11,249 | $225,010 | $93,578 |
All Medicare Procedures & Services
61 procedure records from CMS Medicare Utilization — Page 2 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2022 | 17 | 17 | $2,020 | $463.55 | 22.9% |
| 94664 | Evaluation of use of breathing device | Office | 2022 | 12 | 12 | $492.00 | $123.86 | 25.2% |
| 96160 | Administration and interpretation of patient-focused health risk assessment | Office | 2022 | 45 | 54 | $1,783 | $96.85 | 5.4% |
| 95165 | Preparation and provision of single or multiple antigens for allergen immunotherapy | Office | 2021 | 97 | 2,900 | $72,500 | $30,797 | 42.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 115 | 180 | $26,100 | $16,980 | 65.1% |
| 95117 | Injection of incremental dosages of allergen, 2 or more injections | Office | 2021 | 306 | 1,615 | $53,295 | $11,625 | 21.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 145 | 190 | $19,000 | $10,945 | 57.6% |
| 95004 | Injection of allergenic extracts into skin, accessed through the skin | Office | 2021 | 44 | 3,376 | $33,760 | $9,923 | 29.4% |
| 95024 | Injection of allergenic extracts into skin for immediate reaction analysis | Office | 2021 | 40 | 1,488 | $20,912 | $9,232 | 44.1% |
| 95180 | Rapid desensitization procedure, each hour | Office | 2021 | 12 | 50 | $11,750 | $4,965 | 42.3% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 42 | 42 | $9,240 | $4,873 | 52.7% |
| 94010 | Measurement and graphic recording of total and timed exhaled air capacity | Office | 2021 | 120 | 198 | $14,850 | $4,060 | 27.3% |
| 95012 | Measurement of inhaled nitric oxide gas | Office | 2021 | 109 | 167 | $5,845 | $2,283 | 39.1% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 15 | 107 | $4,353 | $1,061 | 24.4% |
| 94060 | Measurement and graphic recording of the amount and speed of breathed air, before and following medication administration | Office | 2021 | 27 | 27 | $2,970 | $924.50 | 31.1% |
| 95115 | Injection of incremental dosages of allergen | Office | 2021 | 39 | 162 | $4,050 | $853.64 | 21.1% |
| 90688 | Vaccine for influenza for administration into muscle, 0.5 ml dosage, quadrivalent | Office | 2021 | 16 | 16 | $560.00 | $317.82 | 56.8% |
| 94664 | Demonstration and/or evaluation of patient use of aerosol generator, nebulizer, metered dose inhaler or intermittent positive pressure breathing (ippb) device | Office | 2021 | 14 | 15 | $615.00 | $182.09 | 29.6% |
| 96160 | Administration and interpretation of patient-focused health risk assessment | Office | 2021 | 65 | 84 | $2,772 | $158.97 | 5.7% |
| 95165 | Preparation and provision of single or multiple antigens for allergen immunotherapy | Office | 2020 | 99 | 2,760 | $57,070 | $27,790 | 48.7% |
| 95004 | Injection of allergenic extracts into skin, accessed through the skin | Office | 2020 | 55 | 4,249 | $35,668 | $12,202 | 34.2% |
| 95024 | Injection of allergenic extracts into skin for immediate reaction analysis | Office | 2020 | 51 | 1,813 | $19,178 | $10,573 | 55.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 164 | 218 | $21,715 | $10,548 | 48.6% |
| 95117 | Injection of incremental dosages of allergen, 2 or more injections | Office | 2020 | 282 | 1,332 | $34,414 | $8,848 | 25.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 80 | 105 | $15,025 | $8,026 | 53.4% |
About Dr. David Pallares, M.D
Dr. David Pallares, M.D is a Allergy & Immunology healthcare provider based in Louisville, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1023082484.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Pallares, M.D has received a total of $23,211 in payments from pharmaceutical and medical device companies, with $3,074 received in 2024. These payments were reported across 797 transactions from 42 companies. The most common payment nature is "Food and Beverage" ($22,890).
As a Medicare-enrolled provider, Pallares has provided services to 4,393 Medicare beneficiaries, totaling 42,417 services with total Medicare billing of $397,229. Data is available for 4 years (2020–2023), covering 61 distinct procedure/service records.
Practice Information
- Specialty Allergy & Immunology
- Other Specialties Allergy & Immunology
- Location Louisville, KY
- Active Since 02/14/2006
- Last Updated 05/26/2021
- Taxonomy Code 207K00000X
- Entity Type Individual
- NPI Number 1023082484
Products in Payments
- DUPIXENT (Biological) $2,640
- FASENRA (Biological) $1,804
- NUCALA (Biological) $1,172
- TEZSPIRE (Biological) $1,100
- TRELEGY ELLIPTA (Drug) $1,048
- Hizentra (Biological) $834.33
- FASENRA (Drug) $698.87
- Ozempic (Drug) $677.81
- BREZTRI (Drug) $634.16
- Haegarda (Biological) $633.69
- FARXIGA (Drug) $524.56
- CUVITRU (Biological) $461.06
- UBRELVY (Drug) $460.10
- AUVI-Q (Drug) $437.00
- Xolair (Biological) $431.28
- DUPIXENT DUPILUMAB INJECTION (Biological) $411.94
- STIOLTO RESPIMAT (Drug) $397.25
- AirDuo Digihaler (Drug) $384.17
- BEXSERO (Biological) $359.34
- SYMBICORT (Drug) $339.51
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Allergy & Immunology Doctors in Louisville
James Sublett, M.d, M.D
Allergy & Immunology — Payments: $540,567
Stephen Pollard, M.d, M.D
Allergy & Immunology — Payments: $322,437
Douglas Lotz, M.d, M.D
Allergy & Immunology — Payments: $212,066
Dr. Mark Corbett, M.d, M.D
Allergy & Immunology — Payments: $154,857
Dr. Jeremy Jones, Md, MD
Allergy & Immunology — Payments: $152,692
Dr. Kali Gerace, M.d, M.D
Allergy & Immunology — Payments: $21,883